Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | CD1a CAR T cells |
| Synonyms | |
| Therapy Description |
CD1a CAR T cells are T-lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting CD1a and containing 4-1BB and CD3zeta signaling domains, which potentially induce cytotoxicity in tumor cells and inhibit tumor growth (PMID: 30796021). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| CD1a CAR T cells | CD1a CAR T cells are T-lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting CD1a and containing 4-1BB and CD3zeta signaling domains, which potentially induce cytotoxicity in tumor cells and inhibit tumor growth (PMID: 30796021). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT05679895 | Phase I | CD1a CAR T cells | Safety and Efficacy of OC-1 Therapy in Patients With R/R T-ALL/LL (CARxALL) | Recruiting | ESP | 0 |